The Role of Monoclonal Antibodies in the Management of Leukemia

This article will review the monoclonal antibodies more commonly used in leukemias. In the last three decades, scientists have made considerable progress understanding the structure and the functions of various surface antigens, such as CD20, CD33. The introduction of rituximab, an anti CD20 monoclo...

Full description

Bibliographic Details
Main Authors: Mohamad Cherry, Aref Al-Kali, Ali Al-Ameri, Alessandra Ferrajoli
Format: Article
Language:English
Published: MDPI AG 2010-10-01
Series:Pharmaceuticals
Subjects:
CLL
AML
ALL
Online Access:http://www.mdpi.com/1424-8247/3/10/3258/